The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
- PMID: 10613829
- DOI: 10.1038/71577
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
Abstract
Replication-competent HIV-1 can be isolated from infected patients despite prolonged plasma virus suppression by anti-retroviral treatment. Recent studies have identified resting, memory CD4+ T lymphocytes as a long-lived latent reservoir of HIV-1 (refs. 4,5). Cross-sectional analyses indicate that the reservoir is rather small, between 103 and 107 cells per patient. In individuals whose plasma viremia levels are well suppressed by anti-retroviral therapy, peripheral blood mononuclear cells containing replication-competent HIV-1 were found to decay with a mean half-life of approximately 6 months, close to the decay characteristics of memory lymphocytes in humans and monkeys. In contrast, little decay was found in a less-selective patient population. We undertook this study to address this apparent discrepancy. Using a quantitative micro-culture assay, we demonstrate here that the latent reservoir decays with a mean half-life of 6.3 months in patients who consistently maintain plasma HIV-1 RNA levels of fewer than 50 copies/ml. Slower decay rates occur in individuals who experience intermittent episodes of plasma viremia. Our findings indicate that the persistence of the latent reservoir of HIV-1 despite prolonged treatment is due not only to its slow intrinsic decay characteristics but also to the inability of current drug regimens to completely block HIV-1 replication.
Similar articles
-
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.Nat Med. 1999 May;5(5):512-7. doi: 10.1038/8394. Nat Med. 1999. PMID: 10229227
-
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.N Engl J Med. 1999 May 27;340(21):1605-13. doi: 10.1056/NEJM199905273402101. N Engl J Med. 1999. PMID: 10341272 Clinical Trial.
-
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.Nat Med. 2000 Jul;6(7):757-61. doi: 10.1038/77481. Nat Med. 2000. PMID: 10888923
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
Cited by
-
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.Nat Commun. 2019 Jul 19;10(1):3193. doi: 10.1038/s41467-019-10884-9. Nat Commun. 2019. PMID: 31324762 Free PMC article.
-
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.J Virol. 2010 Mar;84(6):2913-22. doi: 10.1128/JVI.02356-09. Epub 2009 Dec 23. J Virol. 2010. PMID: 20032180 Free PMC article.
-
Regulation of HIV-1 latency by T-cell activation.Cytokine. 2007 Jul;39(1):63-74. doi: 10.1016/j.cyto.2007.05.017. Epub 2007 Jul 20. Cytokine. 2007. PMID: 17643313 Free PMC article. Review.
-
Effect of latent human immunodeficiency virus infection on cell surface phenotype.J Virol. 2002 Feb;76(4):1673-81. doi: 10.1128/jvi.76.4.1673-1681.2002. J Virol. 2002. PMID: 11799162 Free PMC article.
-
Primary cell model for activation-inducible human immunodeficiency virus.J Virol. 2007 Jul;81(14):7424-34. doi: 10.1128/JVI.02838-06. Epub 2007 May 2. J Virol. 2007. PMID: 17475639 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials